SLXN logo
SLXN NASDAQ IL

Silexion Therapeutics Corp - Ordinary Shares

Healthcare · Biotechnology Website · IPO Feb 2021
$1.21
▼ $-0.01 (-0.82%)
Vol 21K
2
Quality Score
fail
Mkt Cap
$6.0M
ROE
-232.4%
D/E
22.07
Beta
-0.04
52W
$2–$52

Wall Street Consensus

8 analysts · Apr 2026
2
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating

Price Chart

Earnings

Beat rate: 20.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-1.14 $-1.40 $-0.26
Sep 2025 $-3.47 $-2.88 +$0.59
Jun 2025 $-3.67 $-4.32 $-0.65
Mar 2025 $-3.37 $-3.90 $-0.53

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -313.2% -72.0% -313.2% -313.2% -313.2% -232.4%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 2658.33 115.74 2658.33 2658.33 2658.33 22.07
Current Ratio 2.44 3.22 2.44 2.44 2.44 3.97

Key Ratios

ROA (TTM)
-129.4%
EPS (TTM)
$-25.21
52W High
$51.75
52W Low
$2.13
$2.13 52-Week Range $51.75

How does SLXN compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

SLXN AAPG ABEO ABOS ABP

SLXN valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0% below peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

SLXN profitability vs Biotechnology peers

ROE
-232.4%
245% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-129.4%
177% below peers (-46.7%)
vs Peers
vs Industry
Weak

SLXN financial health vs Biotechnology peers

D/E ratio
22.1
0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
4.0
11% below peers (4.4)
vs Peers
vs Industry
In line
Beta
0.0
104% below peers (1.0)
vs Peers
vs Industry
More volatile

SLXN fundamentals radar

SLXN Peer median Industry

SLXN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

SLXN vs peers: key metrics

Latest News

No related news yet